Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Term ID:6416
Name:Leydig Cell Hypoplasia
Definition:
Alternative IDs:OMIM:238320
ParentIDs:MESH:D058490
TreeNumbers:C12.706.316.096/C562567 |C13.351.875.253.096/C562567 |C16.131.939.316.096/C562567 |C19.391.119.096/C562567 |F03.800.399.750/C562567
Synonyms:46,XY Disorder of Sex Development Due To LH Defects |Hypergonadotropic Hypogonadism, Male, Due To LHCGR Defect |HYPERGONADOTROPIC HYPOGONADISM, MALE, DUE TO LHCGR DEFECT, INCLUDED |Leydig Cell Agenesis |LEYDIG CELL AGENESIS LEYDIG CELL HYPOPLASIA, TYPE II, I
Slim Mappings:Congenital abnormality|Endocrine system disease|Mental disorder|Urogenital disease (female)|Urogenital disease (male)
Reference: MedGen: C562567
MeSH: C562567
OMIM: 238320;

Genes: LHCGR;
Phenotypes
1 HP:0000007Autosomal recessive inheritance
2 HP:0000815Hypergonadotropic hypogonadism
3 HP:0000837Increased circulating gonadotropin level
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_000233.3(LHCGR):c.1777G>C (p.Ala593Pro)-1-Pathogenic121912520RCV000015465; RCV000015466; NMedGen:C0266432,OMIM:238320,SNOMED CT:56212008; MedGen:C267349824891515948915159NM_000233.3:c.1777G>CNP_000224.2:p.Ala593ProNC_000002.11:g.48915159C>GOMIM Allelic Variant:152790.0004C0266432 238320 Leydig cell agenesis; C2673498 Luteinizing hormone resistance, female
NM_000233.3(LHCGR):c.1660C>T (p.Arg554Ter)-1-Pathogenic121912524RCV000015470; RCV000015471; NMedGen:C0266432,OMIM:238320,SNOMED CT:56212008; MedGen:C267349824891527648915276NM_000233.3:c.1660C>TNP_000224.2:p.Arg554TerNC_000002.11:g.48915276G>AOMIM Allelic Variant:152790.0008C0266432 238320 Leydig cell agenesis; C2673498 Luteinizing hormone resistance, female
NM_000233.3(LHCGR):c.1635C>A (p.Cys545Ter)-1-Pathogenic121912523RCV000015469; NMedGen:C0266432,OMIM:238320,SNOMED CT:5621200824891530148915301NM_000233.3:c.1635C>ANP_000224.2:p.Cys545TerNC_000002.11:g.48915301G>TOMIM Allelic Variant:152790.0007C0266432 238320 Leydig cell agenesis
NM_000233.3(LHCGR):c.1627T>C (p.Cys543Arg)-1-Pathogenic121912537RCV000015464; NMedGen:C0266432,OMIM:238320,SNOMED CT:5621200824891530948915309NM_000233.3:c.1627T>CNP_000224.2:p.Cys543ArgNC_000002.11:g.48915309A>GOMIM Allelic Variant:152790.0026C0266432 238320 Leydig cell agenesis
NM_000233.3(LHCGR):c.1505T>C (p.Leu502Pro)-1-Pathogenic121912538RCV000015491; NMedGen:C0266432,OMIM:238320,SNOMED CT:5621200824891543148915431NM_000233.3:c.1505T>CNP_000224.2:p.Leu502ProNC_000002.11:g.48915431A>GOMIM Allelic Variant:152790.0027C0266432 238320 Leydig cell agenesis
NM_000233.3(LHCGR):c.1060G>A (p.Glu354Lys)-1-Pathogenic121912529RCV000015477; RCV000015478; NMedGen:C0266432,OMIM:238320,SNOMED CT:56212008; MedGen:C267349824891587648915876NM_000233.3:c.1060G>ANP_000224.2:p.Glu354LysNC_000002.11:g.48915876C>TOMIM Allelic Variant:152790.0014C0266432 238320 Leydig cell agenesis; C2673498 Luteinizing hormone resistance, female
NM_000233.3(LHCGR):c.1027T>A (p.Cys343Ser)-1-Pathogenic121912536RCV000015490; NMedGen:C0266432,OMIM:238320,SNOMED CT:5621200824891590948915909NM_000233.3:c.1027T>ANP_000224.2:p.Cys343SerNC_000002.11:g.48915909A>TOMIM Allelic Variant:152790.0025C0266432 238320 Leydig cell agenesis
NM_000233.3(LHCGR):c.430G>T (p.Val144Phe)-1-Pathogenic121912539RCV000015492; NMedGen:C0266432,OMIM:238320,SNOMED CT:5621200824895078948950789NM_000233.3:c.430G>TNP_000224.2:p.Val144PheNC_000002.11:g.48950789C>AOMIM Allelic Variant:152790.0028C0266432 238320 Leydig cell agenesis